Take Action Before the July 31 Deadline…

Get Your 100% Free Copy of
The Company that Will Put an End to
America’s #1 Cause of Death

Thanks for being a part of my presentation today.

I hope you learned something about the coming biotech boom under Trump.

Even more, I hope you’re excited about the profit potential for the company set to end the heart disease epidemic in America.

I don’t want you to leave without something valuable to take away.

With that in mind, please accept your free copy of Dr. Skousen’s new report: The Company That Will Put an End to America’s #1 Cause of Death

You’ll find all the details on a company that could turn every $500 into $58,022.

They’ve got a treatment for heart disease that could save 200,000 patients per year, right here in America.

As you’ve seen, companies with breakthrough treatments in the medical field have rewarded investors massively over the years.

Aquinox Pharmaceuticals went from $2 to $55 in two trading days… simply because they got back good results on a treatment for bladder pain.

Medivation created a way to ease the pain of Alzheimer’s, and its stock went from 20 cents to over $81.

Illumina created gene-sequencing technology, and that stock jumped from 88 cents to $219!

$500 in each of these three biotechs would have turned into $341,968!

You’ll have a chance to get in on the next big biotech story by receiving Dr. Skousen’s report today.

But that’s not all…

There are more biotechs about to score massive gains under Trump’s new legislation.

And Dr. Skousen has two new reports available for you now.

The Next $3 Billion Pharmaceutical Company: The company has two treatments, already approved, generating over $250 million in annual revenue. But they have three more drugs in the late stages of approval, and two of them are estimated to have “a market potential exceeding $3 billion per year.” This one could be a 1,000% winner.

The #1 Company Solving the Healthcare Cost Crisis: Healthcare premiums are expected to spike another 25% in 2017, but this company’s mission is to “reduce the cost of care” by creating non-invasive approaches to healthcare issues. And it has a history of doing what it says, receiving awards for innovations in patient safety, newborn care, best new health product, and tech innovation. We see it as another 10-bagger or more in the coming months.

That’s three biotech opportunities you’ll get 100% free just by taking a 90-day test-drive of Dr. Skousen’s Forecasts & Strategies.

Plus, here’s everything else you’ll get when you activate your trial run now:

  • Wealth-Building Report #1: Skousen’s Five Favorite High Income Investments
  • Wealth-Building Report #2: Forecasts & Strategies Quick Start Guide
  • Special Bonus: Access to Dr. Skousen’s Personal Hotline
  • One Full Year of Forecasts & Strategies Issues
  • Other Exclusive, Members-Only Benefits

Dr. Skousen runs one of the longest-lasting and most successful newsletter publications of all time.

He’s written for 37+ years without ever missing a deadline.

And his ability to call the markets is legendary, prompting industry praise like this….

Stephen Halprin, editor of The Stock Advisors, runs a contest each year between all the leading newsletter publishers. Everyone submits a pick at the beginning of the year, and then Stephen gives out awards at the end of the year.

Here’s what Halprin had to say about Dr. Skousen…

“For over 25 years, I have conducted an annual feature asking the nation’s leading newsletter advisors to select their favorite stock for the coming year. Year after year, Mark has consistently been among the top performers in this contest. Indeed, out of some 100 financial advisors, Mark has ranked in the top few spots more than any other.”

The recommendations you receive in the coming year could dramatically increase your portfolio.

Plus, the value of the free special reports alone comes in at $395.

That said, Forecasts & Strategies usually costs $249 per year.

But, for a very short time, we’re offering a 1-year subscription at one of the best rates we’ve ever offered.

You’ll get in at a price of just $49.95 – or about 13.5 cents per day!

To get started now, and get all your free reports in minutes, just fill out your information below.

But remember, the deadline to get in is July 31.

Good investing,

Roger Michalski
Publisher, Eagle Financial Publications

Eagle Financial Publishing Guarantee: We’d like to offer you 90 days to try Forecasts & Strategies risk-free. You’ll receive everything promised right away, including password protected access to the website.  During your 90-day trial, take your time. Track the performance of Dr. Skousen’s recommendations. See if his calls on the market are accurate. I can promise you’ll be very impressed. After 37+ years, I’m awfully confident in his work. But know that you are always protected. If you decide you’re not ready to commit to building your wealth during that first 90 days, you can get 100% of your money back. That’s our promise to you.



Good Value
  1. The Company that Will Put an End to America’s #1 Cause of Death
  2. The Next $3 Billion Per Year Pharmaceutical Company
  3. The #1 Company Solving the Healthcare Cost Crisis
  4. Dr. Skousen’s Five Favorite High Income Investments
  5. Forecasts & Strategies Quick Start Guide


Best Value!
  1. The Company that Will Put an End to America’s #1 Cause of Death
  2. The Next $3 Billion Per Year Pharmaceutical Company
  3. The #1 Company Solving the Healthcare Cost Crisis
  4. Dr. Skousen’s Five Favorite High Income Investments
  5. Forecasts & Strategies Quick Start Guide
  6. How to Survive and Prosper from Rising Interest Rates
  7. Lucrative Loopholes: 4 Ways to Keep More of Your Money Out of the Taxman’s Reach
Choose Your Membership Below (For New Subscribers Only)